← Back to Search

Observational No Musical Toxicity Group for Brain Cancer

N/A
Waitlist Available
Led By Dean A. Shumway, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This study evaluates the experience of musicians who are going through cancer treatment.

Eligible Conditions
  • Brain Cancer
  • Esophageal Cancer
  • Cancer
  • Head and Neck Cancers
  • Lung Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Describe specific musical difficulties that arise during and after cancer treatments - MTQ 10-item

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Observational No Musical Toxicity GroupExperimental Treatment1 Intervention
Patients have their medical records reviewed on study.
Group II: Observational Musical Toxicity GroupExperimental Treatment1 Intervention
Patients complete a questionnaire, participate in an interview and their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,430 Total Patients Enrolled
Dean A. Shumway, M.D.Principal InvestigatorMayo Clinic in Rochester
~43 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top